WALUANA TOMLIN: Open Payments
NPI 1417164930 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,932 in 93 payments from 15 companies in 2025. Trend: 2023 $351 · 2024 $738 · 2025 $1,932
Food & beverage: $1,932
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $604 |
| GlaxoSmithKline, LLC. | 24 | $411 |
| Regeneron Healthcare Solutions, Inc. | 9 | $268 |
| Verona Pharma, Inc. | 10 | $160 |
| United Therapeutics Corporation | 3 | $94 |
| Actelion Pharmaceuticals US, Inc. | 3 | $65 |
| GENZYME CORPORATION | 3 | $60 |
| Viatris Specialty LLC | 2 | $58 |
| Insmed, Inc. | 2 | $45 |
| Baxter Healthcare | 2 | $37 |
Products named: BREZTRI, DUPIXENT, NUCALA, FASENRA, Ohtuvayre, TRELEGY ELLIPTA, Tyvaso, UPTRAVI.
Industry payments across CA — which companies pay providers there.
